Using Functional Near-Infrared Spectroscopy to Predict Outcomes in Stroke Rehabilitation
Prognostic Value for Predicting Outcome Using Functional Near-infrared Spectroscopy in Stroke Rehabilitation
This study is testing if a special brain scan can help predict how well people will recover from a stroke during their rehabilitation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 136 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Seoul National University Bundang Hospital Academic / other |
| Locations | 1 site (Seongnam-si, Korea, Gyeonggi-do) |
| Trial ID | NCT04288414 on ClinicalTrials.gov |
What this trial studies
This study investigates the prognostic value of Functional Near-Infrared Spectroscopy (fNIRS) in stroke rehabilitation by conducting serial measurements at various stages of recovery. Participants will undergo fNIRS assessments immediately after transfer to rehabilitation, at discharge, and during follow-up one to three months post-stroke. The primary goal is to evaluate the prediction rate of outcomes based on fNIRS parameters alongside clinical assessments. Secondary outcomes include various functional and cognitive assessments to correlate with fNIRS data.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with a stroke and can provide informed consent.
Not a fit: Patients with traumatic brain injuries or other neurological conditions that impair cognitive function may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the ability to predict rehabilitation outcomes for stroke patients, leading to more personalized treatment plans.
How similar studies have performed: While the use of fNIRS in stroke rehabilitation is a relatively novel approach, similar studies have shown promising results in other neurological conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 or above. * Diagnosed as stroke (infarction/hemorrhage) with imaging studies. * Participants who have given consent after listening to the full explanations of this study. * Able to understand the contents of this study and is able to sign to the written consent by his/herself. * A legal representative has given written consent for those who meet the inclusion criteria but is unable to understand and agree by themselves due to impaired cognition, a legal representative. Exclusion Criteria: * Traumatic brain injury. * Unable to perform simple commands (motor task during fNIRS scan) due to impaired cognition. * Current symptoms are caused by diseases other than stroke (e.g., dementia, Parkinson's disease) * Participants with any symptoms that may hinder the compliance or evaluation (e.g., delirium and agitation) process. * Participants with any uncontrolled disorders.
Where this trial is running
Seongnam-si, Korea, Gyeonggi-do
- Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital — Seongnam-si, Korea, Gyeonggi-do, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: Nam-Jong Paik, Ph.D — Seoul National University Bundang Hospital, Seongnam, South Korea
- Study coordinator: Nam-Jong Paik, Ph.D
- Email: njpaik@snu.ac.kr
- Phone: 82-31-787-7731
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.